title: Replenishment of glutathione levels improves mucosal function in experimental acute colitis.
abstract: Because reactive oxygen species (ROS) have been implicated as mediators of inflammatory bowel disease (IBD), the purpose of the present work was to determine the functional role of mucosal GSH in the trinitrobenzenesulfonic acid in 50% ethanol (TNBS+ethanol)-induced colitis in rats. Mucosal samples were taken to evaluate the temporal relationship between the extent of injury, the levels of glutathione (GSH) during acute colitis induced by TNBS+ethanol, and the effect of N-acetylcysteine (NAC) administration. In vitro assays revealed the interaction of TNBS with GSH leading to the almost instantaneous disappearance of GSH, while the reductive metabolism of TNBS by GSSG reductase generated ROS. Mucosal samples from TNBS+ethanol-treated rats indicated a direct correlation between GSH depletion and injury detected as soon as 30 minutes after TNBS+ethanol administration that persisted 24 hours post treatment. Although, short term depletion of mucosal GSH per se by diethylmaleate did not result in mucosal injury, the oral administration of NAC (40 mM) 4 hours after TNBS+ethanol treatment increased GSH stores (2-fold), decreasing the extent of mucosal injury (60-70%) examined at 24 hours post treatment. However, an equimolar dose of dithiothreitol failed to increase GSH levels and protect mucosa from TNBS+ethanol-induced injury. Interestingly, GSH levels in TNBS+ethanol-treated rats recovered by 1-2 weeks, an effect that was accounted for by an increase of gamma-glutamylcysteine synthetase (gamma-GCS) activity due to an induction of gamma-GCS-heavy subunit chain mRNA. Thus, TNBS promotes two independent mechanisms of injury, GSH depletion and ROS generation, both being required for the manifestation of mucosal injury as GSH limitation renders intestine susceptible to the TNBS-induced ROS overgeneration. Accordingly, in vivo administration of NAC attenuates the acute colitis through increased mucosal GSH levels, suggesting that GSH precursors may be of relevance in the acute relapse of IBD.
authors.affiliation: Liver Unit, Institut Malalties Digestives, Instituto Investigaciones Biomedicas August Pi I Suñer, Consejo Superior Investigaciones Cientificas, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Ardite
authors.forename: M
authors.initials: M
authors.lastname: Sans
authors.forename: J
authors.initials: J
authors.lastname: Panés
authors.forename: F J
authors.initials: FJ
authors.lastname: Romero
authors.forename: J M
authors.initials: JM
authors.lastname: Piqué
authors.forename: J C
authors.initials: JC
authors.lastname: Fernández-Checa
mesh_terms: D000111:Acetylcysteine / Q000494:pharmacology; D000208:Acute Disease; D000818:Animals; D003092:Colitis / Q000378:metabolism*; D000431:Ethanol / Q000633:toxicity; D005978:Glutathione / Q000502:physiology*; D015212:Inflammatory Bowel Diseases / Q000209:etiology; D007413:Intestinal Mucosa / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species; D013997:Time Factors; D014302:Trinitrobenzenesulfonic Acid / Q000633:toxicity
chemical_list: D017382:Reactive Oxygen Species; D000431:Ethanol; D014302:Trinitrobenzenesulfonic Acid; D005978:Glutathione; D000111:Acetylcysteine